Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001162194-22-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-24 | 2022-02-22 | LAB | Linthwaite Stephen Christopher | Pres, CEO | F - Tax | $3.62 | -12.5K | 328.5K | -4% | -$45.1K |
| DM | 2022-02-24 | 2022-02-22 | LAB | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | +22.4K | 326.3K | +7% | $0 |
| DM | 2022-02-24 | 2022-02-22 | LAB | Linthwaite Stephen Christopher | Pres, CEO | M - OptEx | $0.00 | -22.4K | 61.8K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-22 | F | D | 12,465 | $3.62 | 328,473 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-22 | M | A | 7,722 | $0.00 | 340,938 | D | — | — | |
| 3 | Common | Common Stock | 2022-02-22 | M | A | 6,882 | $0.00 | 333,216 | D | — | — | |
| 4 | Common | Common Stock | 2022-02-22 | M | A | 7,813 | $0.00 | 326,334 | D | — | — | (F1) Includes 3,297 shares purchased on November 30, 2021 under the Company's 2017 Employee Stock Purchase Plan. |
| 5 | Derivative | Restricted Stock Units | 2022-02-22 | M | D | 7,813 | $0.00 | 7,813 | D | — · — to — | 7,813 Common Stock | (F2) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F3) On June 11, 2018, the Reporting Person was granted 125,000 Restricted Stock Units vesting as to 1/16th of the total number of shares on August 20, 2018, and as to 1/16th of the total number of shares each quarter thereafter. |
| 6 | Derivative | Restricted Stock Units | 2022-02-22 | M | D | 6,882 | $0.00 | 27,528 | D | — · — to — | 6,882 Common Stock | (F2) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F4) On February 19, 2019, the Reporting Person was granted 110,112 Restricted Stock Units vesting as to 1/4th of the total number of shares on February 20, 2020, and as to 1/16th of the total number of shares each quarter thereafter. |
| 7 | Derivative | Restricted Stock Units | 2022-02-22 | M | D | 7,722 | $0.00 | 61,779 | D | — · — to — | 7,722 Common Stock | (F2) Each Restricted Stock Unit represents the contingent right to receive one share of FLDM common stock. (F5) On March 10, 2020, the Reporting Person was granted 123,555 Restricted Stock Units vesting as to 1/4th of the underlying shares on February 20, 2021, and as to 1/16th of the total number of shares each quarter thereafter. |